- Organon (OGN, Financial) is set to release its Q2 2025 financial results on August 5, 2025.
- A conference call will follow the release at 8:30 a.m. EDT.
- Access the live webcast on the Organon website.
Organon (OGN), a healthcare company specializing in women's health, has announced that it will release its second quarter 2025 financial results on August 5, 2025. The results will be made available before a scheduled webcast and conference call at 8:30 a.m. EDT. This event offers stakeholders an opportunity to get insights into the company's latest financial performance and strategic direction.
Interested parties can access the live webcast through the Organon website at Organon Investor Relations. For those who are unable to attend the live session, a replay will be accessible approximately two hours after the event concludes. Institutional investors and analysts who wish to participate in the call can do so by dialing (888) 596-4144 (U.S. and Canada Toll-Free) or (646) 968-2525, and using the access code Conference ID: 1036555#.
Headquartered in Jersey City, New Jersey, Organon aims to address health needs that uniquely, disproportionately, or differently affect women, with an extensive portfolio of over 70 products across Women's Health and General Medicines. The company is committed to improving access to essential treatments in over 140 markets globally.
Stay updated on Organon's progress by following them on LinkedIn, Instagram, X, YouTube, TikTok, and Facebook.
